[Liver resection--indications and results].
BACKGROUND
Liver resection is an established treatment for malignancies like colorectal metastases and hepatocellular carcinoma.


METHODS
Indications and outcomes of liver resection at the National Hospital, Oslo, Norway was studied retrospectively in 226 patients operated between 1977 and 1999.


RESULTS
The main indication for surgery was colorectal metastases (n = 137). The frequency of liver resection for colorectal malignancies was < 1 per 100,000 patients per year in the hospital's catchment area. Other indications included hepatocellular carcinoma (n = 30), benign tumours like hemangioma (n = 14), and various primary and secondary malignant tumours. Reoperation due to postoperative complications was performed in 13 patients (6%). Total perioperative mortality defined as death before hospital discharge or within 30 days after discharge, was 3% (7/226). No perioperative deaths occurred among the 159 patients operated after 1987. Five year survival for patients operated for colorectal metastases and hepatocellular carcinoma were 29% and 24%, respectively.


CONCLUSIONS
The main indication for liver resection is colorectal metastases. Liver resection is a safe operation with potential curation for selected patients.
Mala
T
T
Seksjon for gastroenterologisk kirurgi/Intervensjonssenteret, Rikshospitalet 0027 Oslo. tom.mala@Rikshospitalet.no
Bergan
A
A
Edwin
B
B
Gladhaug
I
I
Mathisen
Ø
Ø
D000293:Adolescent; D000328:Adult; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000556:secondary / Q000601:surgery*; D015179:Colorectal Neoplasms / Q000401:mortality / Q000556:secondary / Q000601:surgery*; D005260:Female; D006498:Hepatectomy / Q000009:adverse effects / Q000379:methods / Q000592:standards; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality / Q000556:secondary / Q000601:surgery*; D008297:Male; D008488:Medical Illustration; D008875:Middle Aged; D012086:Reoperation; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome